牙周炎与糖尿病对肥胖炎症的影响存在差异
该研究从横断面招募的受试者采集外周血单个核细胞(PBMC),分析牙周炎(PD)对肥胖和/或2型糖尿病(T2D)患者T细胞及髓系细胞因子分泌的影响。结果显示,PD显著改变肥胖者T细胞和髓系来源的炎症,而在T2D中仅改变髓系来源的炎症;T2D合并IV期PD者的PBMC产生的T细胞和髓系细胞因子低于II-III期PD者。结论认为PD与T2D通过重叠但不完全相同的机制影响肥胖者的全身炎症。
要点
- 牙周炎显著改变肥胖者T细胞和髓系来源的全身炎症。
- 牙周炎在T2D中仅改变髓系而非T细胞来源的炎症。
- T2D合并IV期PD者PBMC产生的细胞因子低于II-III期PD者。
核心结论
- 牙周炎与T2D在肥胖中通过重叠但不完全相同的机制影响全身炎症。
- 需同时评估口腔与代谢状态以识别牙周炎与全身疾病的关联机制。
- IV期PD在T2D中产生较少细胞因子,可解释免疫系统在PD中表现激活或抑制的矛盾现象。
研究设计与样本
- 横断面研究,采集受试者外周血单个核细胞(PBMC)。
- 用Bioplex定量T细胞或髓系靶向激活剂刺激PBMC分泌的细胞因子。
- 采用偏最小二乘判别分析(PLS-DA)组合分析结果。
主要发现
- PD显著改变肥胖者T细胞和髓系来源的炎症。
- PD在T2D中改变髓系但未改变T细胞来源的炎症。
- T2D改变PD者的炎症,PD改变T2D者的炎症,符合双向关系。
- T2D合并IV期PD者的PBMC产生的T细胞和髓系细胞因子低于II-III期PD者。
临床怎么用
- 临床应同时评估牙周状态与代谢状态(超越肥胖本身)。
- 报告PD分期对解释免疫激活或抑制结果至关重要。
- 评估PD全身效应需关注多种细胞来源的细胞因子。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Periodontitis (PD) potentiates systemic inflammatory diseases and fuels a feed-forward loop of pathogenic inflammation in obesity and type 2 diabetes (T2D). Published work in this area often conflates obesity with obesity-associated T2D; thus, it remains unclear whether PD similarly affects the inflammatory profiles of these 2 distinct systemic diseases. We collected peripheral blood mononuclear cells (PBMCs) from cross-sectionally recruited subjects to estimate the ability of PD to affect cytokine production in human obesity and/or T2D. We analyzed 2 major sources of systemic inflammation: T cells and myeloid cells. Bioplex quantitated cytokines secreted by PBMCs stimulated with T cell- or myeloid-targeting activators, and we combinatorially analyzed outcomes using partial least squares discriminant analysis. Our data show that PD significantly shifts peripheral T cell- and myeloid-generated inflammation in obesity. PD also changed myeloid- but not T cell-generated inflammation in T2D. T2D changed inflammation in samples from subjects with PD, and PD changed inflammation in samples from subjects with T2D, consistent with the bidirectional relationship of inflammation between these 2 conditions. PBMCs from T2D subjects with stage IV PD produced lower amounts of T cell and myeloid cytokines compared with PBMCs from T2D subjects with stage II to III PD. We conclude that PD and T2D affect systemic inflammation through overlapping but nonidentical mechanisms in obesity, indicating that characterizing both oral and metabolic status (beyond obesity) is critical for identifying mechanisms linking PD to systemic diseases such as obesity and T2D. The finding that stage IV PD cells generate fewer cytokines in T2D provides an explanation for the paradoxical findings that the immune system can appear activated or suppressed in PD, given that many studies do not report PD stage. Finally, our data indicate that a focus on multiple cellular sources of cytokines will be imperative to clinically address the systemic effects of PD in people with obesity.
引用
- SantaCruz-Calvo S, Saraswat S, Hasturk H, et al. Periodontitis and Diabetes Differentially Affect Inflammation in Obesity. J Dent Res. 2024. PMID: 39382110. doi:10.1177/00220345241280743
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。